The Use of Indirect Immune-fluorescence Antibody Testing (IFAT) IgM And IgG In the Diagnosis of Melioidosis
DOI:
https://doi.org/10.31344/ijhhs.v5i3.280Keywords:
Melioidosis, Indirect Immunofluorescent Antibody Test, Cut-off.Abstract
Introduction: Meliodosis is an important public health disease caused byBurkholderiapseudomallei. Early laboratory diagnosis is crucial for appropriate treatment due to its high mortality rate.
Objective: This study is conducted to assess the potential role of the in-house IFAT IgM and IgG as the serodiagnostic tool in melioidosis and to determine the cut-off levels.
Method: 40 culture-confirmed melioidosis patients were recruited. Controls consisted of a group of 40 patients without active infection and another group of 40 patients with positive blood culture for organisms other thanBurkholderiapseudomallei.
Results and Discussion: Using the receiver operating characteristic (ROC) curve, the best cut-off levels determined to diagnose melioidosis are 1:20 for IgM and 1:80 for IgG. Of these cut off levels, the sensitivity and specificity for IgM are 72.5% and 80% respectively and 65% and 87.5%respectively for IgG which also has high background seropositivity.
Conclusion: IFAT IgM at the cut-off level 1:20 is recommended for diagnosis.
International Journal of Human and Health Sciences Vol. 05 No. 03 July’21 Page: 307-314
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Arumugam Janaki, Nur Raziana Binti Rozi, Mohammed Imad A Mustafa Mahmud, Jamalludin Bin Ab Rahman, Ahmad Kashfi Bin Hj Ab Rahman, How Soon Hin

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the International Journal of Human and Health Sciences agree to the following terms that:
- Authors retain copyright and grant International Journal of Human and Health Sciences the right of first publication of the work.

Articles in International Journal of Human and Health Sciences are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.